by June Song | Aug 1, 2020 | News
Nanjing, China, April 25-27, 2013 — Company CEO, Dr. Haifeng Chen, chaired the Gene Therapy session and presented Virovek’s latest suicide gene therapy technology using toxins to target cancer cells at the BIT’s 4th Annual World DNA and Genome Day...
by June Song | Aug 1, 2020 | News
San Francisco, California, January 7-9, 2013 — Virovek presented its newest patented technology to manufacture AAV vectors harboring toxins, the first of its kind, at the Biotech Showcase 2013 where private and small- and mid-cap biotechnology companies present...
by June Song | Aug 1, 2020 | News
San Francisco, California, and Houston, TX, May 16, 2012 — Avalanche Biotechnologies, Inc. and Lonza announced their major global manufacturing collaboration to use Virovek’s patented technologyto produce AAV vectors for gene therapy...
by June Song | Aug 1, 2020 | News
Hayward, California, June 10, 2011 — Virovek announced that a new book “Methods in Molecular Biology 737 — Viral Vector for Gene Therapy” has been published by Humana Press (Editors: Otto-Wilhelm Merten & Mohamed Al-Rubeai), in which Dr. Haifeng Chen contributed...
by June Song | Aug 1, 2020 | News
Hayward, California, November 20, 2009 — Virovek announced today that starting on January 1, 2010, Virovek will provide up to 50% discount in fees of AAV vector production services for academic and non-profit organizations in order to facilitate the use of AAV vectors...
by June Song | Aug 1, 2020 | News
Hayward, California, April 10, 2009 — Virovek announced today that it launched a new product, BacEZ Titer Kit, for baculovirus titration. This kit offers customer more reagents for lower cost as compared with other competitors’ similar product. It uses a standard...
